TELA Bio, Inc. Additional Paid in Capital
TELA Bio, Inc. (TELA) had Additional Paid in Capital of $405.10 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2026-08-11
- 2026-06-30: Additional Paid in Capital $405.10M.
- 2026-03-31: Additional Paid in Capital $404.50M.
- 2025-12-31: Additional Paid in Capital $403.74M.
- 2025-09-30: Additional Paid in Capital $389.95M.
| Period end | Additional Paid in Capital |
|---|---|
| 2026-06-30 | $405.10M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $404.50M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $403.74M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $389.95M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $388.97M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $387.99M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $387.06M 10-K · filed 2026-03-25 |
| 2024-09-30 | $343.08M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $341.90M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $340.81M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $339.65M 10-K · filed 2025-03-21 |
| 2023-09-30 | $338.39M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $336.94M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $289.25M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $288.36M 10-K · filed 2024-03-22 |
| 2022-09-30 | $287.27M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $251.85M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $250.82M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $250.06M 10-K · filed 2023-03-23 |
| 2021-09-30 | $249.07M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $248.08M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $246.55M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $245.74M 10-K · filed 2022-03-23 |
| 2020-09-30 | $245.20M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $244.54M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $199.29M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $198.83M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |